glp-1 medication cost 2025 Novo cuts prices 70%, but semaglutide revenue could grow in 2026 Pharmacy costs didn't just rise

Aug 18: Regeneron Pharmaceuticals Veopoz (pozelimab) secured FDA approval as the first and only treatment indicated specifically for CHAPLE disease, also known as CD55-deficient protein-losing enteropathy, an ultra-rare hereditary disease that can cause potentially life-threatening gastrointestinal and cardiovascular symptoms

HbA1c

We offer the GLP-1 Daily Support supplement to assist with this process

BWFI contains benzyl alcohol, which acts as a preservative and protects against bacterial growth without affecting the stability of the peptide solution

A thoughtful low carb approach ensures that weight loss comes primarily from fat, not muscle, while supporting energy, digestion, and metabolic health

Exploring peptides for gut health may offer additional support for the gut-brain axis during GLP-1 therapy